Haemonetics Corporation (HAE) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Haemonetics Corporation

    NYSE: HAE · Real-Time Price · USD
    54.44
    0.36 (0.67%)
    At close: Sep 05, 2025, 3:59 PM
    54.38
    -0.11%
    After-hours: Sep 05, 2025, 05:38 PM EDT

    Haemonetics Income Statement

    Financials in USD. Fiscal year is May - April.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Mar 29, 2025 Mar 30, 2024 Apr 1, 2023 Apr 2, 2022 Apr 3, 2021
    Revenue
    		 1.36B 1.31B 1.17B 993.2M 870.46M
    Cost of Revenue
    		 611.87M 617.51M 553.56M 487.69M 472.63M
    Gross Profit
    		 748.96M 691.55M 615.1M 505.5M 397.84M
    Operating Income
    		 221.82M 164.88M 156.03M 80.75M 57.96M
    Interest Income
    		 n/a n/a 13M 5.8M 9.4M
    Pretax Income
    		 212.07M 151.87M 141.4M 63.63M 72.91M
    Net Income
    		 167.68M 117.56M 115.4M 43.38M 79.47M
    Selling & General & Admin
    		 436.79M 431.78M 376.68M 339.56M 274.19M
    Research & Development
    		 62.72M 54.44M 50.13M 46.8M 32.86M
    Other Expenses
    		 27.63M 40.45M 32.26M 47.41M 32.83M
    Operating Expenses
    		 527.14M 526.66M 459.06M 433.78M 339.88M
    Interest Expense
    		 9.75M 13.02M 14.63M 17.12M 16.83M
    Selling & Marketing Expenses
    		 n/a 7.1M 7.2M 4.4M 2.7M
    Cost & Expenses
    		 1.14B 1.14B 459.06M 921.47M 812.5M
    Income Tax Expense
    		 44.39M 34.31M 26M 20.25M -6.56M
    Shares Outstanding (Basic)
    		 50.33M 50.71M 50.78M 51.05M 50.69M
    Shares Outstanding (Diluted)
    		 50.73M 51.4M 51.42M 51.35M 51.29M
    EPS (Basic)
    		 3.31 2.32 2.27 0.85 1.57
    EPS (Diluted)
    		 3.31 2.29 2.24 0.84 1.55
    EBITDA
    		 337.4M 265.58M 249.34M 178.5M 142.25M
    EBIT
    		 221.82M 164.88M 156.03M 80.75M 89.75M
    Depreciation & Amortization
    		 115.59M 97.22M 93.31M 97.75M 84.29M

    Add to Watchlist